Based on previous findings in different populations [25–29], we aimed to find out if the variability in EGF and EGFR genes, their interaction, and expression constitute risk factors or disease markers of RE/BE/EAC development and progression in the Central European population. The gene discussed is EGF; the disease is Barrett esophagus.